State Street’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-117,128
| Closed | -$529K | – | 4288 |
|
|
2025
Q4 | $529K | Sell |
117,128
-7,705
| -6% | -$39.5K | ﹤0.01% | 3662 |
|
|
2025
Q3 | $673K | Buy |
124,833
+68,581
| +122% | +$371K | ﹤0.01% | 3601 |
|
|
2025
Q2 | $305K | Buy |
56,252
+1,246
| +2% | +$4.94K | ﹤0.01% | 3725 |
|
|
2025
Q1 | $152K | Buy |
55,006
+4,179
| +8% | +$14.5K | ﹤0.01% | 3885 |
|
|
2024
Q4 | $173K | Buy |
50,827
+777
| +2% | +$2.24K | ﹤0.01% | 3882 |
|
|
2024
Q3 | $147K | Buy |
50,050
+476
| +1% | +$1.57K | ﹤0.01% | 3889 |
|
|
2024
Q2 | $169K | Buy |
49,574
+987
| +2% | +$3.23K | ﹤0.01% | 3867 |
|
|
2024
Q1 | $147K | Buy |
48,587
+1,680
| +4% | +$5.9K | ﹤0.01% | 3941 |
|
|
2023
Q4 | $197K | Sell |
46,907
-82,041
| -64% | -$445K | ﹤0.01% | 3901 |
|
|
2023
Q3 | $881K | Buy |
128,948
+2,343
| +2% | +$20.7K | ﹤0.01% | 3560 |
|
|
2023
Q2 | $1.32M | Sell |
126,605
-139,617
| -52% | -$1.25M | ﹤0.01% | 3539 |
|
|
2023
Q1 | $1.86M | Buy |
266,222
+8,821
| +3% | +$76.9K | ﹤0.01% | 3364 |
|
|
2022
Q4 | $1.55M | Buy |
257,401
+181,348
| +238% | +$1.34M | ﹤0.01% | 3447 |
|
|
2022
Q3 | $599K | Sell |
76,053
-35,207
| -32% | -$410K | ﹤0.01% | 3710 |
|
|
2022
Q2 | $1.51M | Sell |
111,260
-530,059
| -83% | -$8.77M | ﹤0.01% | 3543 |
|
|
2022
Q1 | $12.6M | Buy |
641,319
+38,172
| +6% | +$762K | ﹤0.01% | 2689 |
|
|
2021
Q4 | $20.7M | Buy |
603,147
+72,363
| +14% | +$2.91M | ﹤0.01% | 2458 |
|
|
2021
Q3 | $29M | Buy |
530,784
+54,057
| +11% | +$3.26M | ﹤0.01% | 2205 |
|
|
2021
Q2 | $35M | Buy |
476,727
+468,027
| +5,380% | +$46.8M | ﹤0.01% | 2113 |
|
|
2021
Q1 | $796K | Buy |
+8,700
| New | +$844K | ﹤0.01% | 3669 |
|
State Street's CVAC Position: Q1 2026 in Review
State Street sold out of CureVac (CVAC) in Q1 2026, closing a stake of 117,128 shares — an estimated $529K sold.
State Street first reported a position in CVAC in Q1 2021 and held it in 20 quarters. The position peaked at $35M in Q2 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- State Street reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- State Street sold 117,128 CureVac shares in Q1 2026, an estimated $529K.
- State Street first reported a position in CureVac in Q1 2021 and held it in 20 quarters.
- State Street's CureVac position peaked at $35M in Q2 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.